台股 » 個股 » 松瑞藥 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

松瑞藥

(4167)
可現股當沖
  • 股價
    20.05
  • 漲跌
    ▲0.10
  • 漲幅
    +0.50%
  • 成交量
    659
  • 產業
    上櫃 生技醫療類股▲0.61%
  • 279人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
松瑞藥 (4167)籌碼相關-元富-新興 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元富-新興 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/14019.9000.0019.8001,0530.00%
2025/01/06021.3000.0021.4009500.00%
2025/01/0300.00321.5021.25-3952-0.31%
2024/12/13419.8500.0019.9548930.45%
2024/11/21120.65020.7020.6011,0370.10%
2024/11/11221.5300.0021.4521,2800.16%
2024/10/29022.6500.0022.4001,4060.00%
2024/10/28023.2000.0022.7501,3830.00%
2024/10/24122.2000.0022.0511,3290.08%
2024/10/1600.00121.0021.15-11,463-0.07%
2024/09/2300.00121.7521.75-13,567-0.03%
2024/09/1600.000.421.7521.90-0.44,047-0.01%
2024/08/30123.3000.0023.1515,4180.02%
2024/08/29123.60423.8023.10-35,434-0.06%
2024/08/23122.6500.0022.6515,4500.02%
2024/08/22622.8400.0022.8065,4570.11%
2024/08/2100.00222.9522.70-25,459-0.04%
2024/08/20323.0511.523.1522.70-8.55,439-0.16%
2024/08/19221.2500.0021.2525,3070.04%
2024/08/07120.85121.0020.9505,7110.00%
2024/08/051921.2900.0020.00195,7300.33%
2024/08/02822.5600.0022.1085,6910.14%
2024/07/2300.00122.8522.85-15,766-0.02%
2024/07/22122.4500.0022.4515,7730.02%
2024/07/17223.40223.5023.3005,7730.00%
2024/07/15223.60223.4523.2005,8410.00%
2024/07/12223.35223.6323.2005,8520.00%
2024/07/11423.26423.2523.1505,8970.00%
2024/07/09323.6700.0023.4535,8650.05%
2024/07/08125.50125.7025.1505,7200.00%
2024/07/05325.72525.8825.70-25,680-0.04%
2024/07/03325.57325.4525.5005,6190.00%
2024/07/02125.80125.9526.0005,5430.00%
2024/07/01826.223326.3526.20-255,456-0.46%
2024/06/281225.55925.6025.5035,1760.06%
2024/06/274027.001726.4726.15234,9950.46%
2024/06/261425.092824.9325.90-144,128-0.34%
2024/06/25223.0500.0023.5523,7500.05%
2024/06/241123.42123.3023.30103,7440.27%
2024/06/21523.674.123.5023.350.93,7220.02%
2024/06/20624.253.123.8523.852.93,6800.08%
2024/06/19424.133324.0423.80-293,641-0.80%
2024/06/18325.00324.9524.6003,5520.00%
2024/06/171624.93324.9525.00133,4550.38%
2024/06/14123.9500.0024.1513,2820.03%
2024/06/13324.551024.3523.95-73,248-0.22%
2024/06/1200.004223.5223.95-423,173-1.32%
2024/06/116924.321324.2923.45563,0541.83%
2024/06/07522.70522.9022.7002,5080.00%
2024/06/061523.123322.9822.45-182,502-0.72%
2024/06/051822.7900.0023.00182,4850.72%
2024/06/0400.00022.2022.2502,4490.00%
2024/05/221022.65222.8022.2582,4010.33%
2024/05/21422.43422.4322.4502,3690.00%
2024/05/2000.00522.9022.95-52,345-0.21%
2024/05/17022.701222.2122.80-122,313-0.52%
2024/05/16122.0500.0021.8512,2680.04%
2024/05/15522.60422.4522.3512,2570.04%
2024/05/14222.60222.8023.0002,2090.00%
2024/05/130.222.8000.0022.850.22,1280.01%
2024/05/10021.7500.0021.9002,0460.00%
2024/05/0800.00121.6021.30-11,994-0.05%
2024/05/06222.20622.1721.80-41,991-0.20%
2024/05/03121.40122.0520.7501,9310.00%
2024/05/02121.55221.7321.55-11,921-0.05%
2024/04/30321.65121.4021.4021,9200.10%
2024/04/29721.07621.2621.4011,9250.05%
2024/04/26321.43421.5021.20-11,918-0.05%
2024/04/24522.1200.0022.0551,9460.26%
2024/04/23422.05621.8321.90-21,943-0.10%
2024/04/22121.651.521.1321.65-0.51,929-0.03%
2024/04/19320.902721.0220.90-241,887-1.27%
2024/04/172421.6700.0022.05241,8401.30%
2024/04/16120.5000.0020.7511,7820.06%
2024/04/15121.2500.0020.9011,8260.05%
2024/04/121221.7000.0021.25121,8570.65%
2024/04/11021.4700.0021.4501,8840.00%
2024/04/10222.15421.7321.75-21,909-0.10%
2024/04/0300.00620.5620.65-62,086-0.29%
2024/03/2900.00119.6519.55-12,131-0.05%
2024/03/28219.6500.0019.6022,2070.09%
2024/03/27419.5300.0019.5042,2950.17%
2024/03/2600.00119.1519.10-12,506-0.04%
2024/03/1300.00118.7518.55-13,940-0.03%
2024/03/11219.20219.1019.0504,4320.00%
2024/03/070.220.0000.0020.500.26,0040.00%
2024/03/05120.35120.1520.1506,7310.00%
2024/03/040.219.9500.0019.850.26,8810.00%
2024/02/27020.4500.0020.4507,0780.00%
2024/02/262.220.75220.8520.900.27,0810.00%
2024/02/2300.00519.9519.85-57,069-0.07%
【新台股龍捲風】看NVIDIA不如看NBI生技,松瑞藥3天逼近3根漲停 迎廣飆漲VS材料大跌,驚天動地33持續!Anue鉅亨-2023/12/05
〈熱門股〉藥品供應吃緊 原料藥中化、松瑞藥周漲逾3成Anue鉅亨-2022/12/17
松瑞藥 相關文章